DEFICIENT INACTIVATION OF CORTISOL BY 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN ESSENTIAL-HYPERTENSION

被引:171
作者
WALKER, BR
STEWART, PM
SHACKLETON, CHL
PADFIELD, PL
EDWARDS, CRW
机构
[1] QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[2] CHILDRENS HOSP, RES INST, OAKLAND, CA 94609 USA
关键词
D O I
10.1111/j.1365-2265.1993.tb01778.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE 11beta-Hydroxysteroid dehydrogenase protects renal mineralocorticoid receptors from cortisol by converting cortisol to inactive cortisone. 11beta-Dehydrogenase deficiency, either congenital or after inhibition by liquorice and carbenoxolone, results in cortisol-dependent mineralocorticoid excess and hypertension. We tested the hypothesis that the same mechanism occurs in some patients with essential hypertension. DESIGN/PATIENTS Twenty patients with essential hypertension were compared with 19 matched healthy controls. MEASUREMENTS 11beta-Hydroxysteroid dehydrogenase activity was assessed by the half-life of 11alpha-H-3-cortisol, and by the ratios of cortisol to cortisone in plasma and of their metabolites in urine. Renal mineralocorticoid receptor activation was assessed by plasma potassium, renin activity and aldosterone. RESULTS Half-lives of 11alpha-H-3-cortisol were prolonged in a subgroup of hypertensives (mean +/- SE 53.2 +/- 3.6 min in hypertensives vs 42.3 +/- 2-3 in controls, P < 0.05; seven of the 20 hypertensives had half-lives exceeding 2 SD of controls). Ratios of cortisol to cortisone in plasma and of their metabolites in urine were not different. 11alpha-H-3-Cortisol half-lives correlated with blood pressure but not with indices of renal mineralocorticoid receptor activation. CONCLUSIONS 11beta-Dehydrogenase is defective in a proportion of patients with essential hypertension. The normal ratios of cortisol to cortisone in plasma and of their metabolites in urine, also seen after carbenoxolone administration, suggest that 11beta-reductase conversion of cortisone to cortisol is also defective. Unlike other syndromes of 11beta-dehydrogenase deficiency, the defect was not associated with mineralocorticoid excess. We suggest that it may cause hypertension by increasing exposure of vascular steroid receptors to cortisol.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 36 条
  • [1] AGARWAL AK, 1989, J BIOL CHEM, V264, P18939
  • [2] LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
    EDWARDS, CRW
    BURT, D
    MCINTYRE, MA
    DEKLOET, ER
    STEWART, PM
    BRETT, L
    SUTANTO, WS
    MONDER, C
    [J]. LANCET, 1988, 2 (8618) : 986 - 989
  • [3] HORMONES AND HYPERTENSION
    FRASER, R
    DAVIES, DL
    CONNELL, JMC
    [J]. CLINICAL ENDOCRINOLOGY, 1989, 31 (06) : 701 - 746
  • [4] MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    SMITH, AI
    [J]. SCIENCE, 1988, 242 (4878) : 583 - 585
  • [5] VASCULAR TYPE-I ALDOSTERONE BINDING-SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    CAMPBELL, J
    [J]. ENDOCRINOLOGY, 1989, 125 (04) : 2224 - 2226
  • [6] HABER E, 1969, J CLIN ENDOCR METAB, V33, P52
  • [7] EFFECT OF ADRENAL SUPPRESSION WITH DEXAMETHASONE IN ESSENTIAL HYPERTENSION
    HAMILTON, BP
    ZADIK, Z
    EDWIN, CM
    HAMILTON, JH
    KOWARSKI, AA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (05) : 848 - 853
  • [8] RENAL CAPTURE AND OXIDATION OF CORTISOL IN MAN
    HELLMAN, L
    NAKADA, F
    ZUMOFF, B
    FUKUSHIMA, D
    BRADLOW, HL
    GALLAGHER, TF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) : 52 - +
  • [9] CORTICOSTEROIDS IN HUMAN-BLOOD .8. CORTISOL METABOLITES IN PLASMA OF NORMOTENSIVE SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION
    KORNEL, L
    MIYABO, S
    SAITO, Z
    CHA, RW
    WU, FT
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (06) : 949 - 958
  • [10] KORNEL L, 1992, 9TH P INT C END, P142